4 Cheap Tech Stocks to Buy With Huge Upside Potential

Print Email

Micron Technology

Micron Technology Inc. (NASDAQ: MU) is a global leader in advanced semiconductor systems. Micron’s broad portfolio of high-performance memory technologies, including DRAM, NAND and NOR Flash, is the basis for solid state drives, modules, multichip packages and other system solutions. The company’s memory chip solutions enable the world’s most innovative computing, consumer, enterprise storage, networking, mobile, embedded and automotive applications.

Micron and Intel announced recently the availability of their 3D NAND technology, the world’s highest-density flash memory. Flash is the storage technology used inside the lightest laptops, fastest data centers and nearly every cell phone, tablet and mobile device.

Wall Street analysts agree that while DRAM pricing was weaker than expected in the first quarter, the company has taken solid supply-side actions that should help firm pricing. With the potential for another slow quarter, the sell-off in the stock is providing patient investors an incredible entry point.

The Stifel price target is set at $41, and the consensus target is lower at $37.30. Shares closed Thursday at $24.46.

Mellanox Technologies

This fabless chip company may provide outstanding upside for shareholders the rest of the year. Mellanox Technologies Ltd. (NASDAQ: MLNX) is a leading supplier of end-to-end InfiniBand and Ethernet interconnect solutions and services for servers and storage. Mellanox interconnect solutions increase data center efficiency by providing the highest throughput and lowest latency, delivering data faster to applications and unlocking system performance capability. Mellanox offers a choice of fast interconnect products: adapters, switches, software, cables and silicon that accelerate application runtime and maximize business results for a wide range of markets, including high-performance computing, enterprise data centers, Web 2.0, cloud, storage and financial services.

ALSO READ: Merrill Lynch Raises Price Targets on Top Cybersecurity Stocks to Buy

The company recently unveiled the industry’s first 100 gigabit Ethernet, Open Ethernet-based, non-blocking switch. Spectrum, the next generation of its Open Ethernet-based switch IC, overcomes current data center challenges by providing a highly flexible and scalable solution that allows businesses to deploy the hardware-software combinations best suited to meet their unique needs. With Spectrum, Mellanox is the first to offer end-to-end 10/25/40/50 and 100 gigabit Ethernet connectivity.

The Stifel price target is $70, and the consensus target is lower at $59.08. The stock closed Thursday at $51.26 per share.

PROS

This company helps corporations globally deal with big data. PROS Holdings Inc. (NYSE: PRO) is a big data software company that helps customers outperform in their markets by using big data to sell more effectively. The company applies years of data science experience to unlock buying patterns and preferences within transaction data to reveal which opportunities are most likely to close, which offers are most likely to sell and which prices are most likely to win. PROS offers cloud solutions to optimize sales, pricing, quoting, rebates and revenue management across more than 40 industries. PROS has completed over 800 implementations of its solutions in more than 55 countries.

The stock has suffered from negative earnings revisions, and that has taken a toll on the share price. However, the market for big data analytics is huge, and the company has been mentioned as a possible takeover target. The chatter makes sense, as it would be a reasonable bolt-on for a company looking to add the big data silo to product offerings.

The Stifel price target is a massive $35, and the consensus target is $25.43. Shares closed Thursday at $21.73.

ALSO READ: 5 Stocks to Buy With Almost Perfect Balance Sheets

All these companies provide risk-tolerant investors with a low entry point and sizable upside. While the stories behind each could take a while to play out, the value for patient investors could be tremendous.